NASDAQ
-
NASDAQ-listed companies are looking for obesity drugs with the potential for weight loss and muscle gain
If your company is interested in this opportunity, please contact the DrugTimes BD team as soon as possible!
-
This Radiopharma biotech called off the IPO at the last moment before the bell-ringing
DrugTimes will follow up to report further
-
Over 50% of Biotech Companies IPO on NASDAQ in 2024 Still Face Challenges
All comments are warmly welcome! Many thanks!
